Exposure‐safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate

OBJECTIVES: Eslicarbazepine acetate (ESL) is a once‐daily (QD) oral antiepileptic drug (AED) for focal‐onset seizures (FOS). Pharmacokinetic (PK) and pharmacodynamic (PD) models were developed to assess dose selection, identify significant AED drug interactions, and quantitate relationships between...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Neurol Scand
Autors principals: Gidal, B. E., Jacobson, M. P., Ben‐Menachem, E., Carreño, M., Blum, D., Soares‐da‐Silva, P., Falcão, A., Rocha, F., Moreira, J., Grinnell, T., Ludwig, E., Fiedler‐Kelly, J., Passarell, J., Sunkaraneni, S.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099471/
https://ncbi.nlm.nih.gov/pubmed/29732549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ane.12950
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars